Navigation Links
Cumberland Pharmaceuticals Reports Second Quarter 2014 Financial Results
Date:8/5/2014

penicillin. The safety and effectiveness of Omeclamox-Pak in the pediatric population has not yet been established. Omeclamox-Pak was approved by the U.S. Food and Drug Administration in 2011.  For full prescribing information, visit www.omeclamox.com.

About VaprisolVaprisol an intravenous treatment for hyponatremia used in the critical care setting. Hyponatremia is an electrolyte disturbance in which sodium ion concentration in blood plasma is lower than normal.  This can be associated with a variety of critical care conditions including congestive heart failure, liver failure, kidney failure and pneumonia.  The product is a vasopressin receptor antagonist that raises serum sodium levels and promotes free water secretion.  Vaprisol does not require dilution and has a well-defined daily dose of 10 mg, 20 mg, or 40 mg. Vaprisol was approved by the U.S. Food and Drug Administration in 2005 for euvolemic hyponatremia and in 2007 for hypervolemic hyponatremia. For full prescribing information, visit www.vaprisol.com.

Forward-Looking StatementsThis press release contains forward-looking statements, which are subject to certain risks and reflect Cumberland's current views on future events based on what it believes are reasonable assumptions. No assurance can be given that these events will occur. As with any business, all phases of Cumberland's operations are subject to factors outside of its control, and any one or combination of these factors could materially affect Cumberland's results of operations. These factors include market conditions, competition, an inability of manufacturers to produce Cumberland's products on a timely basis or failure of manufacturers to comply with regulations applicable to pharmaceutical manufacturers, maintaining an effective sales and marketing infrastructure and other factors discussed in the Company's most recent Form 10-K a
'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Cumberland Pharmaceuticals Reports First Quarter 2012 Financial Results
2. Cumberland Pharmaceuticals To Present At The 2012 Wells Fargo Securities Healthcare Conference In Boston
3. Cumberland Pharmaceuticals To Announce Second Quarter 2012 Financial Results On August 2, 2012
4. Cumberland Pharmaceuticals Reports Second Quarter 2012 Financial Results
5. Cumberland Pharmaceuticals to Present at the UBS Global Life Sciences Conference in New York
6. Cumberland Pharmaceuticals Reports Third Quarter 2012 Financial Results
7. Cumberland Emerging Technologies Expands Life Sciences Center
8. Cumberland Pharmaceuticals And PT. SOHO Industri Pharmasi enter Into Exclusive Licensing Agreement For Caldolor In Indonesia
9. Cumberland Pharmaceuticals To Announce 2012 Year End Financial Results On February 28, 2013
10. Cumberland Pharmaceuticals Reports 2012 Annual Financial Results
11. Cumberland Pharmaceuticals To Announce First Quarter 2013 Financial Results On May 2, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... BerGenBio AS ("BerGenBio" or the ... has appointed Hilde Furberg and Dr ... of Directors, effective immediately. Hilde Furberg ... and biotech and is currently Senior Vice President Rare ... role was Vice President and General Manager of Nordic ...
(Date:8/31/2015)...  DICOM Grid,  the #1 medical image exchange ... as a semifinalist for a Minnie award for ... are sponsored by Auntminnie.com, a comprehensive community website ... imaging industry.  Since 1999, the "Minnies" have provided ... contributions of their peers. Nominations are made by ...
(Date:8/31/2015)... 2015 Thousands of people will peacefully demonstrate ... opioid addiction epidemic at dozens of rallies across the ... the United States has experienced ... opioids and heroin, yet the President has never once ... letter to President Obama , rally organizers compared ...
Breaking Medicine Technology:BerGenBio Appoints Non-Executive Directors 2DG Suite Nabs "Minnies" Nomination for "Best New Radiology Software" 2Obama Administration's Neglect of Opioid Crisis Prompts Rallies in Many States 2
(Date:9/1/2015)... ... September 01, 2015 , ... Virginia entrepreneur Marcella Ellis, CEO ... maintaining her firm’s success in the hair care and distribution industry through her ... Ellis will be providing “Look and learn” live demonstrations, as well as promoting ...
(Date:9/1/2015)... ... September 01, 2015 , ... PetPace, the ... pet vital signs and activity, today announced its integration with leading veterinary Practice ... and widely-adopted veterinary hospital Practice Management Software packages in the US. Practice Management ...
(Date:9/1/2015)... ... September 01, 2015 , ... Zecurion, a leading developer of data loss prevention ... of endpoint DLP developed specifically for Mac OS. , In June 2015, the company ... and information security professionals had participated. The beta test done by the developer community ...
(Date:9/1/2015)... ... ... SC&H Group, a leading audit, tax, and consulting firm, received multiple honors from ... in the U.S., as well as being ranked a Top 100 Accounting Firm. , ... exclusively on performance in specific areas of financial and operational management. SC&H Group ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... than 1,500 investor-families have received permanent green cards (I-829 petition approval) from the ... I-829 petition is the final step of the EB-5 visa process for immigrant ...
Breaking Medicine News(10 mins):Health News:Beauty Entrepreneur creates hair extension smart machine and mobile app inspired by UBER technology 2Health News:Petpace-Cornerstone Integration Lowers Overhead, Raises Data Visibility for Veterinary Practices 2Health News:Zecurion Announces Endpoint Security for Mac 2Health News:SC&H Group Receives Multiple Honors from INSIDE Public Accounting 2Health News:CanAm Enterprises Reaches Another Milestone with More Than 1,500 I-829 Petition Approvals 2
... 11, 2011, Cleveland: Vincent Tuohy, Ph.D., an Immunologist at ... the winner of Cleveland Clinic,s annual Sones Innovation Award, ... Tuohy was selected by an anonymous review committee for ... breast cancer vaccine. Tuohy,s research found that the vaccine ...
... , THURSDAY, March 10 (HealthDay News) -- You may ... ate poorly during pregnancy, a new study in rats suggests. ... the effects of aging if their mothers were malnourished while ... in the Proceedings of the National Academy of Sciences ...
... new study conducted by researchers at NYU Langone Medical Center ... surgical robotic technology, men in that region are more likely ... Diffusion of the Surgical Robot and Radical Prostatectomy Rates", was ... Medical Care . "The use of the ...
... , THURSDAY, March 10 (HealthDay News) -- ... bones that surgeons should adjust for when they perform ... researchers. Previous studies have found that cerebral palsy ... the hips, but this is the first study to ...
... patients cost about $2,500 more per hospital stay than ... researchers at St. Michael,s Hospital. Homeless people with medical ... health issues and stay longer than others, often because ... initial medical crisis has been treated, the study found. ...
... Barrow Neurological Institute has received a $10.1 million donation, ... one of the biggest ever given to any Arizona ... H. Rochelle to St. Joseph,s Barrow Neurological Institute in ... frontier for psychiatric and motor disorders by using novel ...
Cached Medicine News:Health News:Poor Diet in Pregnancy Tied to Disease in Offspring: Rat Study 2Health News:Acquisition of robotic technology leads to increased rates of prostate cancer surgery 2Health News:Study: Homeless patients cost $2,500 more than the average patient for each hospital stay 2Health News:Deep brain stimulation research expands at Barrow 2Health News:Deep brain stimulation research expands at Barrow 3
The CH 2000 Cardiac Diagnostic system is a fully featured stress testing system that can include Microvolt T-Wave Alternans (MTWA) testing capability as an add-on feature. , ,Interfaces with Tra...
... The Volk G-1 trabeculum provides the highest ... Perfect for viewing and treating the trabecular meshwork. ... of the anterior chamber angle while the central ... view the posterior pole for signs of glaucoma ...
... AFX (Air Fluid eXchange) Lens ... designed for use in an ... its use as a primary ... low profile and sutureless design ...
... The 45° Prism is ... pathologies and are recommended ... (PDR, BRVO etc.) and ... can be used for ...
Medicine Products: